Phio Pharmaceuticals
PHIO
#10949
Rank
NZ$17.8 M
Marketcap
NZ$1.49
Share price
4.82%
Change (1 day)
-45.90%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -NZ$22.47 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$15.44 Million a decrease over its 2024 earnings that were of -NZ$12.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$22.47 Million45.59%
2025 -NZ$15.44 Million21.65%
2024 -NZ$12.69 Million-33.96%
2023 -NZ$19.21 Million-5.7%
2022 -NZ$20.37 Million-13.6%
2021 -NZ$23.58 Million51.09%
2020 -NZ$15.61 Million-1.28%
2019 -NZ$15.81 Million21.03%
2018 -NZ$13.06 Million-53.1%
2017 -NZ$27.85 Million74.49%
2016 -NZ$15.96 Million-12.02%
2015 -NZ$18.14 Million16.17%
2014 -NZ$15.62 Million-57.95%
2013 -NZ$37.13 Million62.45%
2012 -NZ$22.86 Million0.87%
2011 -NZ$22.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion 518.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.22 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA